FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2953240438> ?p ?o ?g. }

• W2953240438 endingPage "1407" @default.
• W2953240438 startingPage "1400" @default.
• W2953240438 abstract "In view of the in vivo demonstrated radiation-potentiating activities of several previously studied 2,2-dimethylphosphoraziridines, six new compounds incorporating the bis(2,2-dimethyl-1-aziridinyl)phosphinyl moiety, together with an electron-affinic group such as 2-nitroimidazole or nitrobenzyl, have been synthesized and tested (1) in vitro for ability to increase the effect of X-irradiation under hypoxic conditions on V-79 Chinese hamster lung fibroblast cells, (2) in vivo for antitumor activity in the absence of radiation against P388 leukemia in mice, and (3) in a preliminary experiment with compound 10 only, in combination with whole-body gamma-radiation, using the P388 leukemia mouse model for in vivo radiation-potentiating activity. The chemical-alkylating activities and hydrolytic behavior of these compounds, as well as their antitumor activities without radiation, were found to be comparable to those of other 2,2-dimethylphosphoraziridines, while their in vitro radiosensitizing activities were at low concentrations generally comparable to that of misonidazole, with compound 8 showing superior activity. At higher concentrations, only compound 10 was sufficiently soluble and nontoxic to the cells for evaluation in this assay. Thus, the bis(2,2-dimethyl-1-aziridinyl) phosphinyl moiety does not seem to have contributed to the hypoxic radiosensitizing activities (only to the cytotoxicities) of the electron-affinic moieties in this in vitro assay. In comparison, the prototype 2,2-dimethylphosphoraziridine, ethyl [bis(2,2-dimethyl-1-aziridinyl) phosphinyl]carbamate (AB-132), showed at nontoxic doses no radiosensitizing activity in this assay, and at cytotoxic doses increased the cell-killing effect of each given dose of X-radiation additively under both hypoxic and oxic conditions. Conversely, only the 2,2-dimethylphosphoraziridine moiety appeared to participate in the moderate therapeutic radiation-potentiating activity indicated by compound 10 in the in vivo experiment using the P388 leukemia model (on day 1), as the misonidazole standard was inactive in this nonhypoxic system. Clearly, the mechanism of the in vivo observed radiation-potentiating effect of AB-132 and other 2,2-dimethylphosphoraziridines is different from that of the hypoxic radiosensitizers, but the possible synergism between the two biologically active moieties of the new compounds could not be demonstrated with the experimental models so far employed." @default.
• W2953240438 created "2019-06-27" @default.
• W2953240438 creator A5030172383 @default.
• W2953240438 creator A5042422517 @default.
• W2953240438 creator A5045213022 @default.
• W2953240438 creator A5047051679 @default.
• W2953240438 creator A5070612253 @default.
• W2953240438 creator A5071435454 @default.
• W2953240438 creator A5080256014 @default.
• W2953240438 creator A5081191902 @default.
• W2953240438 date "1991-04-01" @default.
• W2953240438 modified "2023-09-26" @default.
• W2953240438 title "Synthesis of potential dual-acting radiation sensitizer antineoplastic agents: 2,2-dimethylphosphoraziridines containing 2-nitroimidazoles or other electron-affinic moieties" @default.
• W2953240438 doi "https://doi.org/10.1021/jm00108a024" @default.
• W2953240438 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2016716" @default.
• W2953240438 hasPublicationYear "1991" @default.
• W2953240438 type Work @default.
• W2953240438 sameAs 2953240438 @default.
• W2953240438 citedByCount "8" @default.
• W2953240438 crossrefType "journal-article" @default.
• W2953240438 hasAuthorship W2953240438A5030172383 @default.
• W2953240438 hasAuthorship W2953240438A5042422517 @default.
• W2953240438 hasAuthorship W2953240438A5045213022 @default.
• W2953240438 hasAuthorship W2953240438A5047051679 @default.
• W2953240438 hasAuthorship W2953240438A5070612253 @default.
• W2953240438 hasAuthorship W2953240438A5071435454 @default.
• W2953240438 hasAuthorship W2953240438A5080256014 @default.
• W2953240438 hasAuthorship W2953240438A5081191902 @default.
• W2953240438 hasConcept C150903083 @default.
• W2953240438 hasConcept C185592680 @default.
• W2953240438 hasConcept C202751555 @default.
• W2953240438 hasConcept C207001950 @default.
• W2953240438 hasConcept C2776568683 @default.
• W2953240438 hasConcept C2777755551 @default.
• W2953240438 hasConcept C2781305896 @default.
• W2953240438 hasConcept C55493867 @default.
• W2953240438 hasConcept C71240020 @default.
• W2953240438 hasConcept C86803240 @default.
• W2953240438 hasConceptScore W2953240438C150903083 @default.
• W2953240438 hasConceptScore W2953240438C185592680 @default.
• W2953240438 hasConceptScore W2953240438C202751555 @default.
• W2953240438 hasConceptScore W2953240438C207001950 @default.
• W2953240438 hasConceptScore W2953240438C2776568683 @default.
• W2953240438 hasConceptScore W2953240438C2777755551 @default.
• W2953240438 hasConceptScore W2953240438C2781305896 @default.
• W2953240438 hasConceptScore W2953240438C55493867 @default.
• W2953240438 hasConceptScore W2953240438C71240020 @default.
• W2953240438 hasConceptScore W2953240438C86803240 @default.
• W2953240438 hasIssue "4" @default.
• W2953240438 hasLocation W29532404381 @default.
• W2953240438 hasLocation W29532404382 @default.
• W2953240438 hasOpenAccess W2953240438 @default.
• W2953240438 hasPrimaryLocation W29532404381 @default.
• W2953240438 hasRelatedWork W1992624650 @default.
• W2953240438 hasRelatedWork W1995733966 @default.
• W2953240438 hasRelatedWork W2045060966 @default.
• W2953240438 hasRelatedWork W2085312856 @default.
• W2953240438 hasRelatedWork W2087990253 @default.
• W2953240438 hasRelatedWork W2089118336 @default.
• W2953240438 hasRelatedWork W2414358148 @default.
• W2953240438 hasRelatedWork W2949366517 @default.
• W2953240438 hasRelatedWork W2951269336 @default.
• W2953240438 hasRelatedWork W2953317625 @default.
• W2953240438 hasVolume "34" @default.
• W2953240438 isParatext "false" @default.
• W2953240438 isRetracted "false" @default.
• W2953240438 magId "2953240438" @default.
• W2953240438 workType "article" @default.